Dermatology Made Easy is based on the most popular topics from DermNet NZ's vast array of material. The book combines the essential focus of the ‘Made Easy’ book series with the authority and knowledge base of DermNet NZ's unparalleled resources.
Author: Vanessa Ngan, Staff Writer, 2005.
Cryptococcosis is a fungal infection caused by inhaling the fungus Cryptococcus neoformans, which is primarily found in soils enriched with pigeon droppings. In moist or desiccated pigeon dropping, Cryptococcus neoformans may remain viable for 2 years or longer.
Two varieties of Cryptococcus neoformans exist – neoformans and gattii. Cryptococcus neoformans var neoformans is the most common variety and mainly affects immunosuppressed patients such as those with HIV and AIDS. Cryptococcus neoformans var gattii is much less common but affects mainly immunocompetent (normal immune function) individuals. This variety is restricted to subtropical and tropical areas and the fungus found on eucalyptus trees and the surrounding air.
The most common cryptococcosis infections (Cryptococcus neoformans var neoformans) affect people with immunodeficiency, e.g. patients on high doses of corticosteroids, cancer chemotherapy patients, organ transplantation patients, and patients with acquired immune deficiency (AIDS) and human immunodeficiency virus infection (HIV). With the global emergence of AIDS, cryptococcosis is now one of the most common life-threatening fungal infections in these patients.
Infection is primarily through inhalation of Cryptococcus spores released from soil and bird droppings. It occurs in both humans and animals, but animal-to-human and human-to-human transmission via respiratory droplets has not been documented. Transmission via organ transplantation has been reported when infected donor organs were used. Infection via cuts through the skin is not common but may occur.
The signs and symptoms of the disease are dependent on the site of infection. There are several main sites of infection.
|Site of infection||Features|
|Central Nervous System (CNS)||
|Disseminated (widespread, involving other organs)||
The following laboratory and radiology tests are performed to assist in the diagnosis of cryptococcal disease.
Treatment of cryptococcal disease depends on the patient’s immunological status and the site of infection. It is based on the following categories of infection.
Immunocompetent patients with asymptomatic pulmonary disease do not usually require any treatment. If the disease does not resolve spontaneously then the antifungal fluconazole may be given for 3-6 months.
Treatment goals for categories 2,3 and 4 differ on whether or not the patient also has HIV/AIDS. The goal in infected patients with HIV/AIDS is to first control the infection, followed by life-long treatment to suppress Cryptococcus neoformans. For patients with cryptococcal disease not complicated by HIV/AIDS the treatment goal is to eradicate the fungi and achieve a permanent cure.
Several antifungal medications are used.
See the DermNet NZ bookstore
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.